Vivek Ramaswamy’s Latest News
Vivek Ramaswamy, who is of Indian heritage, entered the race for the presidency of the United States in 2024. He has already launched his campaign for the 2024 elections, however, he is not the only individual of Indian heritage competing in those polls. Nikki Haley has also stated her intent to run in the elections.
Vivek Ramaswamy is a biotech investor and entrepreneur from the United States. On August 9, 1985, he was born in Cincinnati, Ohio, to Indian immigrant parents.
Vivek Ramaswamy Biography
Ramaswamy began his career in biotech investment banking with Qatalyst Partners, a boutique investment bank, where he worked on pharmaceutical mergers and acquisitions. He left Qatalyst in 2013 to join MPM Capital, a healthcare-focused venture capital firm. Ramaswamy oversaw investments in biotech businesses such as Arvinas, Kymera Therapeutics, and TCR2 Therapeutics while at MPM.
Ramaswamy created Roivant Sciences in 2014, a biopharmaceutical firm aimed at developing and commercializing novel medicines for diseases with significant unmet medical needs. Roivant is structured as a “v-family” of subsidiary firms, each focusing on a different therapeutic field or technology platform. Ramaswamy’s ambition for Roivant was to create a decentralized drug development paradigm that might expedite the speed of innovation in the pharmaceutical industry.
Roivant has raised over $3 billion in finance and created many drug development subsidiaries under Ramaswamy’s leadership. Among Roivant’s notable subsidiaries are:
- Axovant Sciences, which is working on gene treatments for neurological illnesses like Parkinson’s and Alzheimer’s.
- Myovant Sciences is working on treatments for women’s health issues such as uterine fibroids and endometriosis.
- Dermavant Sciences is working to create treatments for dermatological disorders like psoriasis and atopic dermatitis.
Roivant has also established subsidiary firms that specialize in drug discovery, drug delivery, and artificial intelligence in medication development. Roivant went public in 2017 after a combination with Axovant Sciences through a special purpose acquisition company (SPAC).
Aside from his work at Roivant, Ramaswamy has been an outspoken advocate for changes in the pharmaceutical business. He has criticized drug prices and the slow rate of innovation and has advocated for greater openness and responsibility in drug pricing. In 2018, Ramaswamy wrote “Woke, Inc.: Inside Corporate America’s Social Justice Hoax,” in which he blasted corporate America’s politicization.
Ramaswamy has been honored for his philanthropy and entrepreneurship. He was included in Forbes’ 30 Under 30 list in healthcare in 2019. In addition, he has donated millions of dollars to philanthropic organizations such as the Alzheimer’s Drug Development Foundation and the American Civil Liberties Union.
Vivek Ramaswamy Quick Info
- Name – Vivek Ramaswamy
- Short Name – Vivek
- Current Age – 37 years old
- Profession Build – American Entrepreneur and author
- Date of Birth – 9 August 1985
- Birth Place – Ohio, United States
- Marital Status – Married
- Spouse Name – Apoorva Tiwari Ramaswamy
- Current Net worth – $600 million (approx)
- Height – 5’7”
- Children – Two
- Hair Color – Black Color
- High School – St. Xavier high school
- College Harvard – University
- Qualification – Graduate
- Zodiac Sign – Leo
- Nationality – American
- Siblings – Shankar Ramaswamy
- Parents – Vivek Ganapathy (Father), Geetha Ramaswamy (Mother)
Vivek Ramaswamy Wife
Vivek Ramaswamy has a wife. His wife’s name is Apoorva Tewari Ramaswamy. She works as an Assistant Professor and Surgeon at the Wexner Medical Center of Ohio State University. This couple has two kids. Read this story until the end to learn more about his relationship, children, parents, and work.
Vivek Ramaswamy Lifestyle-Career
Campus Venture Network was founded in 2007 by Ramaswamy and Travis May as a technology company that provided software and networking possibilities to student entrepreneurs. The Ewing Marion Kauffman Foundation purchased the company in 2009. From 2007 until 2014, Ramaswamy worked as a partner and co-managed QVT Financial’s biotech portfolio while concurrently attending Yale Law School.
Ramaswamy resigned as CEO of Roivant Sciences in order to release Awake, Inc Inside Corporate America’s Social Justice Scam in early 2021. The New York Times bestseller list placed the book at number two. Ramaswamy revealed on Fox News Network Tucker Carlson Tonight on February 21, 2023, that he would run for president in 2024. Ramaswamy describes him as a traditionalist.
Net Worth Of Vivek Ramaswamy
His net worth is $ 600 million (approx).